Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TVRD Tvardi Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.24 -0.8% | $15.90 -2.5% |
| StockIQ Score | 46D+ Moderate Risk: High | 41D Weak Risk: High |
| Technical | 16F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 66B- | 50C- |
| Fair Value | 55C | 38F |
| News | 86A | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Tvardi Therapeutics (TVRD) outperforms Ascentage Pharma (AAPG) in growth and valuation, scoring 66 and 55 respectively, compared to AAPG’s 50 and 38. TVRD also has a stronger overall rating (Moderate vs. Weak) and matches AAPG’s investor score (46 vs. 41), though AAPG leads slightly in technical and fundamental scores (36 vs. 16, 35 vs. 46). TVRD’s higher growth and valuation scores make it the stronger pick in those areas.
